fingolimod-phosphate [Ligand Id: 2924] activity data from GtoPdb and ChEMBL
Click here for a description of the charts and data table
Please tell us if you are using this feature and what you think!
| ChEMBL ligand: CHEMBL114606 |
|---|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
| DB | Assay description | Assay Type | Standard value | Standard parameter | Original value | Original units | Original parameter | Reference |
|---|---|---|---|---|---|---|---|---|
| S1P1 receptor/Sphingosine 1-phosphate receptor Edg-1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4333] [GtoPdb: 275] [UniProtKB: P21453] | ||||||||
| GtoPdb | - | - | 9.52 | pIC50 | 0.3 | nM | IC50 | J Pharmacol Exp Ther (2004) 309: 758-68 [PMID:14747617] |
| ChEMBL | Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 1 expressed on CHO cell membranes | B | 9.55 | pIC50 | 0.28 | nM | IC50 | Bioorg Med Chem Lett (2004) 14: 3351-3355 [PMID:15149705] |
| ChEMBL | Displacement of [33P]sphingosine 1 phosphate from human S1P1 receptor expressed in CHO cells | B | 9.55 | pIC50 | 0.28 | nM | IC50 | J Med Chem (2004) 47: 6662-6665 [PMID:15615513] |
| ChEMBL | Displacement of 33-P-S1P from from human S1P receptor expressed in CHO cell membranes after 50 mins by scintillation counting | B | 10.85 | pIC50 | 0.01 | nM | IC50 | ACS Med Chem Lett (2016) 7: 283-288 [PMID:26985316] |
| ChEMBL | Agonist activity at S1P1 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assay | F | 7.85 | pEC50 | 14 | nM | EC50 | Medchemcomm (2013) 4: 1267-1274 |
| ChEMBL | Agonist activity at human S1P1 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assay | F | 8.04 | pEC50 | 9.1 | nM | EC50 | Eur J Med Chem (2014) 85: 1-15 [PMID:25072873] |
| ChEMBL | Agonist activity at S1P1 (unknown origin) by HTRF assay | B | 8.36 | pEC50 | 4.4 | nM | EC50 | Bioorg Med Chem Lett (2020) 30: 127141-127141 [PMID:32249117] |
| ChEMBL | Agonist activity at S1P1 receptor (unknown origin) expressed in PathHunter CHO-K1 EDG1 beta-arrestin cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by measuring chemiluminescence signal by microplate reader method | F | 8.78 | pEC50 | 1.67 | nM | EC50 | J Med Chem (2022) 65: 3539-3562 [PMID:35077170] |
| ChEMBL | Activity at human S1P1 receptor expressed in HEK293T cells by [35S]GTP-gamma-S binding assay | F | 8.89 | pEC50 | 1.3 | nM | EC50 | Bioorg Med Chem (2007) 15: 663-677 [PMID:17113298] |
| ChEMBL | Effective concentration against sphingosine-1-phosphate receptor 1 determined by a [c-35S]-GTP binding assay | B | 8.89 | pEC50 | 1.3 | nM | EC50 | Bioorg Med Chem Lett (2005) 15: 3568-3572 [PMID:15982878] |
| ChEMBL | Agonism of human S1P-1 receptor expressed in CHO cells, 90-120 min in pH 7.4 using [35S]GTP-gamma-S as radioligand | F | 8.92 | pEC50 | 1.2 | nM | EC50 | J Med Chem (2005) 48: 5373-5377 [PMID:16078855] |
| ChEMBL | Agonist activity at S1P1 receptor (unknown origin) expressed in PathHunter HEK 293 EDG1 Total GPCR Internalization cells assessed as receptor internalization incubated for 90 mins by measuring chemiluminescence signal by microplate reader method | F | 9.15 | pEC50 | 0.7 | nM | EC50 | J Med Chem (2022) 65: 3539-3562 [PMID:35077170] |
| ChEMBL | Agonist activity at recombinant human S1P1 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgammaS binding measured after 45 mins by liquid scintillation counting method | F | 9.15 | pEC50 | 0.7 | nM | EC50 | J Med Chem (2021) 64: 1454-1480 [PMID:33492963] |
| ChEMBL | Agonist activity at human S1P1 receptor by GTPgammaS binding assay | F | 9.42 | pEC50 | 0.38 | nM | EC50 | ACS Med Chem Lett (2016) 7: 283-288 [PMID:26985316] |
| ChEMBL | Agonist activity at human S1P1 receptor expressed in human Chem1 cells assessed as intracellular calcium mobilization | F | 9.46 | pEC50 | 0.35 | nM | EC50 | J Med Chem (2010) 53: 3154-3168 [PMID:20337461] |
| GtoPdb | - | - | 9.5 | pEC50 | - | - | - |
J Biol Chem (2002) 277: 21453-7 [PMID:11967257]; J Pharmacol Exp Ther (2004) 309: 758-68 [PMID:14747617] |
| GtoPdb | - | - | 9.52 | pEC50 | 0.3 | nM | EC50 | J Pharmacol Exp Ther (2004) 309: 758-68 [PMID:14747617] |
| ChEMBL | Activity at human S1P1 receptor expressed in CHO cells by [35S]GTPgammaS binding assay | F | 9.52 | pEC50 | 0.3 | nM | EC50 | J Med Chem (2004) 47: 6662-6665 [PMID:15615513] |
| ChEMBL | Agonist activity at human S1P1 receptor expressed in CHO cells co-expressing GFP assessed as cellular internalization after 45 mins by Hoechst assay | B | 10.15 | pEC50 | 0.07 | nM | EC50 | ACS Med Chem Lett (2016) 7: 283-288 [PMID:26985316] |
| ChEMBL | Agonist activity at human recombinant C-terminal GFP-fused S1P1 expressed in CHO cells assessed as induction of receptor internalization incubated for 50 mins by fluorescence based confocal laser scanning microscopic analysis | B | 10.15 | pEC50 | 0.07 | nM | EC50 | J Med Chem (2021) 64: 1454-1480 [PMID:33492963] |
| ChEMBL | Agonist activity at human recombinant S1P1 expressed in CHO cells assessed as stimulation of ERK phosphorylation incubated for 7 mins by microplate reader analysis | B | 10.7 | pEC50 | 0.02 | nM | EC50 | J Med Chem (2021) 64: 1454-1480 [PMID:33492963] |
| S1P1 receptor in Mouse [GtoPdb: 275] [UniProtKB: O08530] | ||||||||
| GtoPdb | - | - | 9.5 | pEC50 | - | - | - |
J Pharmacol Exp Ther (2008) 324: 276-83 [PMID:17898319]; J Biol Chem (2002) 277: 21453-7 [PMID:11967257] |
| S1P3 receptor/Sphingosine 1-phosphate receptor Edg-3 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3892] [GtoPdb: 277] [UniProtKB: Q99500] | ||||||||
| ChEMBL | Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 3 expressed on CHO cell membranes | B | 8.2 | pIC50 | 6.3 | nM | IC50 | Bioorg Med Chem Lett (2004) 14: 3351-3355 [PMID:15149705] |
| ChEMBL | Displacement of [33P]sphingosine 1 phosphate from human S1P3 receptor expressed in CHO cells | B | 8.2 | pIC50 | 6.3 | nM | IC50 | J Med Chem (2004) 47: 6662-6665 [PMID:15615513] |
| GtoPdb | - | - | 8.3 | pIC50 | 5 | nM | IC50 |
J Biol Chem (2002) 277: 21453-7 [PMID:11967257]; J Pharmacol Exp Ther (2004) 309: 758-68 [PMID:14747617] |
| ChEMBL | Agonist activity at S1P3 receptor (unknown origin) expressed in PathHunter CHO-K1 EDG1 beta-arrestin cells assessed as induction of beta-arrestin 2 recruitment incubated for 90 mins by measuring chemiluminescence signal by microplate reader method | F | 7.01 | pEC50 | 97.7 | nM | EC50 | J Med Chem (2022) 65: 3539-3562 [PMID:35077170] |
| ChEMBL | Agonist activity at S1P3 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assay | F | 7.36 | pEC50 | 44 | nM | EC50 | Medchemcomm (2013) 4: 1267-1274 |
| ChEMBL | Agonist activity at human S1P3 receptor expressed in CHO cells preincubated for 2 hrs before IP1 addition by IP1-HTRF assay | F | 7.45 | pEC50 | 35.1 | nM | EC50 | Eur J Med Chem (2014) 85: 1-15 [PMID:25072873] |
| ChEMBL | Agonist activity at S1PR3 (unknown origin) by HTRF assay | B | 7.87 | pEC50 | 13.6 | nM | EC50 | Bioorg Med Chem Lett (2020) 30: 127141-127141 [PMID:32249117] |
| ChEMBL | Agonist activity at human S1P3 receptor expressed in CHO cells assessed as intracellular calcium mobilization | F | 7.92 | pEC50 | 12 | nM | EC50 | J Med Chem (2010) 53: 3154-3168 [PMID:20337461] |
| ChEMBL | Agonist activity at recombinant human S1P3 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgammaS binding measured after 45 mins by liquid scintillation counting method | F | 8.44 | pEC50 | 3.6 | nM | EC50 | J Med Chem (2021) 64: 1454-1480 [PMID:33492963] |
| ChEMBL | Agonist activity at human S1P3 receptor by GTPgammaS binding assay | F | 8.45 | pEC50 | 3.57 | nM | EC50 | ACS Med Chem Lett (2016) 7: 283-288 [PMID:26985316] |
| ChEMBL | Effective concentration against sphingosine 1-phosphate receptor 3 determined by a [c-35S]-GTP binding assay | B | 8.7 | pEC50 | 2 | nM | EC50 | Bioorg Med Chem Lett (2005) 15: 3568-3572 [PMID:15982878] |
| ChEMBL | Agonism of human S1P-3 receptor expressed in CHO cells, 90-120 min in pH 7.4 using [35S]GTP-gamma-S as radioligand | F | 8.85 | pEC50 | 1.4 | nM | EC50 | J Med Chem (2005) 48: 5373-5377 [PMID:16078855] |
| GtoPdb | - | - | 9.4 | pEC50 | - | - | - |
J Biol Chem (2002) 277: 21453-7 [PMID:11967257]; J Pharmacol Exp Ther (2004) 309: 758-68 [PMID:14747617] |
| ChEMBL | Activity at human S1P3 receptor expressed in HEK293T cells by [35S]GTP-gamma-S binding assay | F | 10 | pEC50 | 0.1 | nM | EC50 | Bioorg Med Chem (2007) 15: 663-677 [PMID:17113298] |
| S1P2 receptor/Sphingosine 1-phosphate receptor Edg-5 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2955] [GtoPdb: 276] [UniProtKB: O95136] | ||||||||
| ChEMBL | Displacement of [33P]sphingosine 1 phosphate from human S1P2 receptor expressed in CHO cells | B | 5.96 | pIC50 | 1100 | nM | IC50 | J Med Chem (2004) 47: 6662-6665 [PMID:15615513] |
| ChEMBL | Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 5 expressed on CHO cell membranes | B | 9.11 | pIC50 | 0.77 | nM | IC50 | Bioorg Med Chem Lett (2004) 14: 3351-3355 [PMID:15149705] |
| ChEMBL | Agonism of human S1P-2 receptor expressed in CHO cells, 90-120 min in pH 7.4 using [35S]GTP-gamma-S as radioligand | F | 5 | pEC50 | >10000 | nM | EC50 | J Med Chem (2005) 48: 5373-5377 [PMID:16078855] |
| GtoPdb | - | - | 7.46 | pEC50 | 35 | nM | EC50 | Mol Pharmacol (2015) 87: 916-27 [PMID:25762025] |
| S1P4 receptor/Sphingosine 1-phosphate receptor Edg-6 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3230] [GtoPdb: 278] [UniProtKB: O95977] | ||||||||
| ChEMBL | Inhibition of [33P]-S1P binding to human Sphingosine 1-phosphate receptor 4 expressed on CHO cell membranes | B | 7.82 | pIC50 | 15 | nM | IC50 | Bioorg Med Chem Lett (2004) 14: 3351-3355 [PMID:15149705] |
| ChEMBL | Displacement of [33P]sphingosine 1 phosphate from human S1P4 receptor expressed in CHO cells | B | 7.82 | pIC50 | 15 | nM | IC50 | J Med Chem (2004) 47: 6662-6665 [PMID:15615513] |
| ChEMBL | Effective concentration against sphingosine 1-phosphate receptor 4 determined by a [c-35S]-GTP binding assay | B | 7.39 | pEC50 | 41 | nM | EC50 | Bioorg Med Chem Lett (2005) 15: 3568-3572 [PMID:15982878] |
| ChEMBL | Activity at human S1P4 receptor expressed in HEK293T cells by [35S]GTP-gamma-S binding assay | F | 8.4 | pEC50 | 4 | nM | EC50 | Bioorg Med Chem (2007) 15: 663-677 [PMID:17113298] |
| ChEMBL | Agonism of human S1P-4 receptor expressed in CHO cells, 90-120 min in pH 7.4 using [35S]GTP-gamma-S as radioligand | F | 8.62 | pEC50 | 2.4 | nM | EC50 | J Med Chem (2005) 48: 5373-5377 [PMID:16078855] |
| ChEMBL | Agonist activity at recombinant human S1P4 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgammaS binding measured after 45 mins by liquid scintillation counting method | F | 8.8 | pEC50 | 1.6 | nM | EC50 | J Med Chem (2021) 64: 1454-1480 [PMID:33492963] |
| GtoPdb | - | - | 9.22 | pEC50 | - | - | - |
Chem Biol (2006) 13: 1227-34 [PMID:17114004]; J Biol Chem (2002) 277: 21453-7 [PMID:11967257]; J Biol Chem (2004) 279: 13839-48 [PMID:14732717]; J Pharmacol Exp Ther (2004) 309: 758-68 [PMID:14747617]; PLoS ONE (2014) 9: e110819 [PMID:25347187] |
| ChEMBL | Agonist activity at human S1P4 receptor by GTPgammaS binding assay | F | 10.05 | pEC50 | 0.09 | nM | EC50 | ACS Med Chem Lett (2016) 7: 283-288 [PMID:26985316] |
| S1P4 receptor in Mouse [GtoPdb: 278] [UniProtKB: Q9Z0L1] | ||||||||
| GtoPdb | - | - | 7.15 | pEC50 | - | - | - |
J Pharmacol Exp Ther (2008) 324: 276-83 [PMID:17898319]; J Biol Chem (2002) 277: 21453-7 [PMID:11967257] |
| S1P5 receptor/Sphingosine 1-phosphate receptor Edg-8 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2274] [GtoPdb: 279] [UniProtKB: Q9H228] | ||||||||
| ChEMBL | Displacement of [33P]sphingosine 1 phosphate from human S1P5 receptor expressed in CHO cells | B | 9.11 | pIC50 | 0.77 | nM | IC50 | J Med Chem (2004) 47: 6662-6665 [PMID:15615513] |
| GtoPdb | - | - | 9.22 | pIC50 | 0.6 | nM | IC50 | J Pharmacol Exp Ther (2004) 309: 758-68 [PMID:14747617] |
| ChEMBL | Effective concentration against sphingosine 1-phosphate receptor 5 determined by a [c-35S]-GTP binding assay | B | 7.4 | pEC50 | 40 | nM | EC50 | Bioorg Med Chem Lett (2005) 15: 3568-3572 [PMID:15982878] |
| ChEMBL | Agonist activity at S1P5 receptor (unknown origin) expressed in CHO cells assessed as inhibition of forskolin-induced cAMP accumulation by GTPgammaS binding assay | F | 7.96 | pEC50 | 11 | nM | EC50 | J Med Chem (2015) 58: 9154-9170 [PMID:26509640] |
| ChEMBL | Agonism of human S1P-5 receptor expressed in CHO cells, 90-120 min in pH 7.4 using [35S]GTP-gamma-S as radioligand | F | 8.31 | pEC50 | 4.9 | nM | EC50 | J Med Chem (2005) 48: 5373-5377 [PMID:16078855] |
| ChEMBL | Activity at human S1P5 receptor expressed in HEK293T cells by [35S]GTP-gamma-S binding assay | F | 8.4 | pEC50 | 4 | nM | EC50 | Bioorg Med Chem (2007) 15: 663-677 [PMID:17113298] |
| ChEMBL | Agonist activity at S1P5 receptor (unknown origin) expressed in CHO cell membranes after 30 mins by GTPgammaS binding assay | F | 8.47 | pEC50 | 3.4 | nM | EC50 | J Med Chem (2015) 58: 9154-9170 [PMID:26509640] |
| ChEMBL | Agonist activity at recombinant human S1P5 expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgammaS binding measured after 45 mins by liquid scintillation counting method | F | 9.17 | pEC50 | 0.67 | nM | EC50 | J Med Chem (2021) 64: 1454-1480 [PMID:33492963] |
| ChEMBL | Agonist activity at human S1P5 receptor by GTPgammaS binding assay | F | 9.4 | pEC50 | 0.4 | nM | EC50 | ACS Med Chem Lett (2016) 7: 283-288 [PMID:26985316] |
| GtoPdb | - | - | 9.52 | pEC50 | - | - | - |
Chem Biol (2006) 13: 1227-34 [PMID:17114004]; J Biol Chem (2002) 277: 21453-7 [PMID:11967257]; J Pharmacol Exp Ther (2004) 309: 758-68 [PMID:14747617] |
ChEMBL data shown on this page come from version 34:
Zdrazil B, Felix E, Hunter F, Manners EJ, Blackshaw J, Corbett S, de Veij M, Ioannidis H, Lopez DM, Mosquera JF, Magarinos MP, Bosc N, Arcila R, Kizilören T, Gaulton A, Bento AP, Adasme MF, Monecke P, Landrum GA, Leach AR. (2024). The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods. Nucleic Acids Res., 52(D1). DOI: 10.1093/nar/gkad1004. [EPMCID:10767899] [PMID:37933841]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]
